HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniel Keeser Selected Research
Daniel Keeser Research Topics
Disease
17
Schizophrenia (Dementia Praecox)
04/2024 - 05/2013
6
Major Depressive Disorder (Major Depressive Disorders)
12/2023 - 12/2017
4
Alzheimer Disease (Alzheimer's Disease)
01/2024 - 03/2016
4
Mental Disorders (Mental Disorder)
09/2023 - 10/2011
3
Neuroinflammatory Diseases
01/2024 - 11/2022
3
Hypertension (High Blood Pressure)
04/2023 - 12/2019
3
Dementia (Dementias)
01/2023 - 11/2014
3
Nervous System Diseases (Neurological Disorders)
01/2022 - 07/2013
2
Mood Disorders (Mood Disorder)
09/2023 - 10/2022
2
Atrophy
07/2023 - 10/2021
2
Tobacco Use Disorder (Nicotine Dependence)
07/2022 - 01/2019
2
Alcoholism (Alcohol Abuse)
06/2022 - 01/2015
2
Treatment-Resistant Depressive Disorder
09/2013 - 01/2009
1
Inborn Genetic Diseases (Disease, Hereditary)
04/2024
1
Retinal Diseases
02/2024
1
Obesity
01/2024
1
Borderline Personality Disorder (Personality Disorders, Borderline)
11/2023
1
Ganglion Cysts (Ganglion)
04/2023
1
Neurobehavioral Manifestations
01/2023
1
Cognitive Dysfunction
01/2023
1
Cardiovascular Diseases (Cardiovascular Disease)
04/2021
1
Hallucinations (Hallucination)
01/2020
1
Catatonia
01/2020
1
Stroke (Strokes)
01/2020
1
Neurodegenerative Diseases (Neurodegenerative Disease)
12/2019
1
Vertigo (Positional Vertigo)
03/2019
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018
1
Parkinson Disease (Parkinson's Disease)
11/2014
1
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
11/2014
1
Treatment-Resistant Schizophrenia
11/2013
Drug/Important Bio-Agent (IBA)
5
Biomarkers (Surrogate Marker)
IBA
02/2024 - 01/2016
5
Amyloid (Amyloid Fibrils)
IBA
01/2024 - 11/2022
4
Retinaldehyde (Retinal)
IBA
04/2024 - 01/2023
3
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
IBA
09/2023 - 02/2023
2
Antipsychotic Agents (Antipsychotics)
IBA
09/2023 - 01/2018
2
Antidepressive Agents (Antidepressants)
IBA
09/2023 - 01/2009
2
salicylhydroxamic acid (SHAM)
IBA
08/2023 - 01/2016
2
Cholesterol
IBA
04/2021 - 12/2019
2
oxidized low density lipoprotein
IBA
04/2021 - 12/2019
1
Silver Sulfadiazine (SSD)
FDA Link
Generic
04/2024
1
Proteins (Proteins, Gene)
FDA Link
01/2024
1
Histamine (Histamine Dihydrochloride)
FDA Link
11/2023
1
Clemastine (Clemastine Fumarate)
FDA Link
Generic
11/2023
1
Psychotropic Drugs (Psychoactive Drugs)
IBA
09/2023
1
Benzodiazepines
IBA
09/2023
1
Cytidine Diphosphate (CDP)
IBA
01/2023
1
LDL Lipoproteins (beta Lipoproteins)
IBA
04/2021
1
Coffee
FDA Link
04/2021
1
Triglycerides (Triacylglycerol)
IBA
04/2021
1
Glutamine (L-Glutamine)
FDA Link
04/2020
1
Glutamic Acid (Glutamate)
FDA Link
04/2020
1
N-acetylaspartate (N-acetyl aspartate)
IBA
04/2020
1
mesoglycan
IBA
01/2020
1
Cholinesterase Inhibitors (Anticholinesterases)
IBA
03/2016
1
Galantamine (Galanthamine)
FDA Link
Generic
03/2016
1
Methylphenidate (Ritalin)
FDA Link
Generic
11/2014
1
Brain-Derived Neurotrophic Factor (BDNF)
IBA
09/2013
Therapy/Procedure
19
Transcranial Direct Current Stimulation
12/2023 - 01/2009
6
Endurance Training
10/2021 - 01/2016
4
Therapeutics
11/2023 - 01/2009
4
Neurofeedback
07/2022 - 01/2015
1
Transcranial Magnetic Stimulation
01/2022
1
Stroke Rehabilitation
01/2020
1
Electrodes (Electrode)
01/2016